Hosted on MSN
OCGN stock rallies on Wall Street optimism for clinical pipeline: Retail awaits new data
・The analyst noted that Ocugen has three clinical stage programs in rare and non-rare retinal diseases including OCU400, OCU410ST and OCU410. ・According to data from Koyfin, all six of the six ...
Oppenheimer frames Ocugen as an emerging gene therapy leader in blinding ocular disorders, with the investment thesis centered squarely on the company’s lead asset, OCU400. The firm views a potential ...
Ocugen Inc. (NASDAQ:OCGN) is one of the popular penny stocks on Robinhood to buy. On March 2, Ocugen, Inc. (NASDAQ:OCGN) announced the completion of patient enrollment for its Phase 3 liMeliGhT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results